INS and cardiac hypertrophy: Deletion or inhibition of CPT-1β can lead to myocardial lipid accumulation, reduced insulin sensitivity, cardiac hypertrophy, cardiac fibrosis, and cardiac dysfunction in mice [19,20,21,22,23].